Respiratory Infections News

My first infectious diseases paper was published when I was 7 months old. Before I was even capable of creating memories and while I was still crawling, my relationship with infectious diseases was off and running.

Most of the emergency use authorizations the FDA issued related to COVID-19 were “not supported by high-quality evidence,” the authors of a cross-sectional study wrote in JAMA Internal Medicine.

Moderna on Monday said that a booster dose of its messenger RNA COVID-19 vaccine, given at the authorized dose of 50 µg, offered a 37-fold increase in protection against the omicron variant, compared with pre-boost levels.

WHO has issued two emergency use listings for Novavax’s COVID-19 vaccine following the publication of positive results from a phase 3 trial, and the company said it expects to begin submitting data to the FDA by the end of the year.

Stories that focused on emerging research and breaking news related to COVID-19 dominated headlines in 2021.

Amid the continuing COVID-19 pandemic, pediatric researchers have been continuing their examinations into the persisting multisystem inflammatory syndrome in children.

Adults who said a health care provider recommended that they receive a COVID-19 vaccine were more likely to get one, data published in MMWR show.

The front page of Infectious Disease News was dominated this year by stories about COVID-19 and its impact on health care.

The omicron variant, which has been in the United States since at least mid-November, has now been confirmed in at least 36 states and more than 75 countries, CDC Director Rochelle P. Walensky, MD, MPH, said Wednesday.

Although influenza activity continues to increase in the United States, it remains low enough that the CDC does not consider the flu season to have started yet, a CDC expert said.